In Silico Study, Synthesis, and In Vitro Evaluation of Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity of Novel N ‐Thiazole Substituted Acetamide Coumarin Derivatives
Chemistry & Biodiversity · 2025-06 · 22 (6)
DOI: 10.1002/cbdv.202401524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 04.02.2025. Verfasst von Pooja Patowary und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Butyrylcholinesterase, Acetylcholinesterase, Coumarins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Department of Health Research (DHR), New Delhi, India.
Abstract (Originalsprache)
In this study, a structurally directed pharmacophore hybridization technique is used to combine the two essential structural scaffolds coumarin and thiazoles in search of a new class of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitor for Alzheimer's disease (AD). A library of 120 compounds was designed in two series 5a ( 1‐15 ), 5b ( 16‐30 ), 5c ( 31‐45 ), 5d ( 46‐60 ), and 6a ( 61‐75 ), 6b ( 76‐90 ), 6c ( 91‐105 ), 6d ( 106‐120 ) using various substituted phenol, β‐ketoesters, and thiazole derivatives. Eleven compounds were identified as potential hybrids using molecular property filter analysis and molecular docking studies, and they comprise N ‐substituted thiazole coumarin derivatives. The docking results indicated that compounds 5b16 and 5c35 exhibited strong binding interactions with GLY116, GLY117, TYR332, and HIS438 (ranging from −27.42 to −24.18 kcal/mol) and GLY119, ASP72, and PHE288 (ranging from −32.21 to −25.92 kcal/mol) when tested against AChE (1EVE) and BuChE (1P0I) inhibitors. These compounds were synthesized via conventional methods and characterized by different spectroscopic methods. In vitro anti‐cholinesterase activity results indicated that two compounds, for example, 5b16 and 5c35 showed potent to moderate activity against AChE and BuChE with IC 50 (2.00 ± 0.09–29.63 ± 0.48) µM and (34.93 ± 0.62–17.92 ± 0.42) µM, respectively. Our study demonstrated the development of a novel class of hybrid coumarin thiazole derivatives as AChE and BuChE inhibitors, and these compounds could be utilized against ADs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
- Institute of Pharmaceutical Science, NETES, Mirza, India.
- Department of Pharmaceutical Sciences, Drug Design and Discovery Laboratory, Sam Higginbottom University of Agriculture Technology and Sciences, Prayagraj, India.
ORCID-Profile: Hans Raj Bhat
Förderung
- Department of Health Research (DHR), New Delhi, India
Zitieren
APA
Patowary, P., Shakya, A., Ghosh, S. K., Jamir, L., Sahariah, B. J., Gogoi, N., Singh, U. P., & Bhat, H. R. (2025). In Silico Study, Synthesis, and In Vitro Evaluation of Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity of Novel N ‐Thiazole Substituted Acetamide Coumarin Derivatives. Chemistry & Biodiversity, 22(6). https://doi.org/10.1002/cbdv.202401524
Vancouver
Patowary P, Shakya A, Ghosh SK, Jamir L, Sahariah BJ, Gogoi N, et al. In Silico Study, Synthesis, and In Vitro Evaluation of Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity of Novel N ‐Thiazole Substituted Acetamide Coumarin Derivatives. Chemistry & Biodiversity. 2025;22(6). doi:10.1002/cbdv.202401524
BibTeX
@article{Patowary2025,
author = {Patowary, Pooja and Shakya, Anshul and Ghosh, Surajit Kumar and Jamir, Lipoksangla and Sahariah, Bhargab Jyoti and Gogoi, Neelutpal and Singh, Udaya Pratap and Bhat, Hans Raj},
title = {In Silico Study, Synthesis, and In Vitro Evaluation of Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity of Novel N ‐Thiazole Substituted Acetamide Coumarin Derivatives},
journal = {Chemistry & Biodiversity},
year = {2025},
volume = {22},
number = {6},
doi = {10.1002/cbdv.202401524}
}
EUVIMED